These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 11924883)
1. A dopamine D3 receptor partial agonist blocks the expression of conditioned activity. Aujla H; Sokoloff P; Beninger RJ Neuroreport; 2002 Jan; 13(1):173-6. PubMed ID: 11924883 [TBL] [Abstract][Full Text] [Related]
2. Intra-BLA or intra-NAc infusions of the dopamine D3 receptor partial agonist, BP 897, block intra-NAc amphetamine conditioned activity. Aujla H; Beninger RJ Behav Neurosci; 2004 Dec; 118(6):1324-30. PubMed ID: 15598141 [TBL] [Abstract][Full Text] [Related]
3. Double dissociation of the effects of haloperidol and the dopamine D3 receptor antagonist ABT-127 on acquisition vs. expression of cocaine-conditioned activity in rats. Banasikowski TJ; Bespalov A; Drescher K; Behl B; Unger L; Haupt A; Schoemaker H; Sullivan JP; Gross G; Beninger RJ J Pharmacol Exp Ther; 2010 Nov; 335(2):506-15. PubMed ID: 20724485 [TBL] [Abstract][Full Text] [Related]
4. The dopamine D(3) receptor-preferring partial agonist BP 897 dose-dependently attenuates the expression of amphetamine-conditioned place preference in rats. Aujla H; Beninger RJ Behav Pharmacol; 2005 May; 16(3):181-6. PubMed ID: 15864073 [TBL] [Abstract][Full Text] [Related]
5. Reduced expression of haloperidol conditioned catalepsy in rats by the dopamine D3 receptor antagonists nafadotride and NGB 2904. Banasikowski TJ; Beninger RJ Eur Neuropsychopharmacol; 2012 Oct; 22(10):761-8. PubMed ID: 22410316 [TBL] [Abstract][Full Text] [Related]
6. Dopamine D3 receptor ligands block nicotine-induced conditioned place preferences through a mechanism that does not involve discriminative-stimulus or antidepressant-like effects. Le Foll B; Sokoloff P; Stark H; Goldberg SR Neuropsychopharmacology; 2005 Apr; 30(4):720-30. PubMed ID: 15562293 [TBL] [Abstract][Full Text] [Related]
7. Effects of a dopamine D3 receptor ligand, BP 897, on acquisition and expression of food-, morphine-, and cocaine-induced conditioned place preference, and food-seeking behavior in rats. Duarte C; Lefebvre C; Chaperon F; Hamon M; Thiébot MH Neuropsychopharmacology; 2003 Nov; 28(11):1903-15. PubMed ID: 12915863 [TBL] [Abstract][Full Text] [Related]
8. The D3R partial agonist, BP 897, attenuates the discriminative stimulus effects of cocaine and D-amphetamine and is not self-administered. Beardsley PM; Sokoloff P; Balster RL; Schwartz JC Behav Pharmacol; 2001 Feb; 12(1):1-11. PubMed ID: 11270507 [TBL] [Abstract][Full Text] [Related]
9. Examining the role of dopamine D2 and D3 receptors in Pavlovian conditioned approach behaviors. Fraser KM; Haight JL; Gardner EL; Flagel SB Behav Brain Res; 2016 May; 305():87-99. PubMed ID: 26909847 [TBL] [Abstract][Full Text] [Related]
10. Dopamine D3 receptor ligands show place conditioning effect but do not influence cocaine-induced place preference. Gyertyán I; Gál K Neuroreport; 2003 Jan; 14(1):93-8. PubMed ID: 12544838 [TBL] [Abstract][Full Text] [Related]
11. Classical conditioning of amphetamine-induced lateralized and nonlateralized activity in rats. Drew KL; Glick SD Psychopharmacology (Berl); 1987; 92(1):52-7. PubMed ID: 3110829 [TBL] [Abstract][Full Text] [Related]
13. Differential ability of D1 and D2 dopamine receptor agonists to induce and modulate expression and reinstatement of cocaine place preference in rats. Graham DL; Hoppenot R; Hendryx A; Self DW Psychopharmacology (Berl); 2007 Apr; 191(3):719-30. PubMed ID: 16835769 [TBL] [Abstract][Full Text] [Related]
14. Disruption of nicotine conditioning by dopamine D(3) receptor ligands. Le Foll B; Schwartz JC; Sokoloff P Mol Psychiatry; 2003 Feb; 8(2):225-30. PubMed ID: 12610655 [TBL] [Abstract][Full Text] [Related]
15. Effects of RGH-237 [N-{4-[4-(3-aminocarbonyl-phenyl)-piperazin-1-yl]-butyl}-4-bromo-benzamide], an orally active, selective dopamine D(3) receptor partial agonist in animal models of cocaine abuse. Gyertyán I; Kiss B; Gál K; Laszlovszky I; Horváth A; Gémesi LI; Sághy K; Pásztor G; Zájer M; Kapás M; Csongor EA; Domány G; Tihanyi K; Szombathelyi Z J Pharmacol Exp Ther; 2007 Mar; 320(3):1268-78. PubMed ID: 17170312 [TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist. Pilla M; Perachon S; Sautel F; Garrido F; Mann A; Wermuth CG; Schwartz JC; Everitt BJ; Sokoloff P Nature; 1999 Jul; 400(6742):371-5. PubMed ID: 10432116 [TBL] [Abstract][Full Text] [Related]
17. BP 897, a selective dopamine D3 receptor ligand with therapeutic potential for the treatment of cocaine-addiction. Garcia-Ladona FJ; Cox BF CNS Drug Rev; 2003; 9(2):141-58. PubMed ID: 12847556 [TBL] [Abstract][Full Text] [Related]
18. Cocaine-seeking behavior in response to drug-associated stimuli in rats: involvement of D3 and D2 dopamine receptors. Cervo L; Carnovali F; Stark JA; Mennini T Neuropsychopharmacology; 2003 Jun; 28(6):1150-9. PubMed ID: 12700684 [TBL] [Abstract][Full Text] [Related]
19. Effects of withdrawal from an escalating dose of amphetamine on conditioned fear and dopamine response in the medial prefrontal cortex. Peleg-Raibstein D; Feldon J Behav Brain Res; 2008 Jan; 186(1):12-22. PubMed ID: 17884189 [TBL] [Abstract][Full Text] [Related]
20. D(3) dopamine receptors are down-regulated in amphetamine sensitized rats and their putative antagonists modulate the locomotor sensitization to amphetamine. Chiang YC; Chen PC; Chen JC Brain Res; 2003 May; 972(1-2):159-67. PubMed ID: 12711089 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]